Results 131 to 140 of about 72,623 (283)

Tetramethylenedisulfotetramine [PDF]

open access: yes, 2014
Tetramethylenedisulfotetramine (CAS 80-12-6), commonly referred to as TETS, was first synthesized in 1933 as a condensation product of sulfamide and formaldehyde. TETS was subsequently used as a rodenticide until banned worldwide in 1991.
Banks, CN   +3 more
core   +1 more source

Unmasking Idiopathic Inflammatory Myopathy: A Case of Proximal Weakness in a Young Male With Co‐Occurring Vitamin D Deficiency

open access: yesClinical Case Reports, Volume 13, Issue 11, November 2025.
ABSTRACT Idiopathic inflammatory myopathy (IIM) encompasses rare autoimmune disorders causing muscle inflammation and weakness, with subtypes including dermatomyositis, necrotizing myopathy, antisynthetase syndrome, and inclusion body myositis. This case report details a 25‐year‐old South Asian male presenting with a 60‐day history of progressive ...
Ibrahim Khalil   +3 more
wiley   +1 more source

Serious Hypokalemia Associated with Abiraterone Acetate in Patients with Castration-Resistant Prostate Cancer

open access: yesCase Reports in Urology, 2018
Introduction The treatment strategy for castration-resistant prostate cancer (CRPC) has changed with the approval of several new agents. In 2011, abiraterone acetate was approved for the treatment of metastatic CRPC; however abiraterone is known to cause
Yutaka Yamamoto   +7 more
semanticscholar   +1 more source

Randomized Phase II Study of Brentuximab‐Vedotin With High‐Dose Chemotherapy in CD30 Positive Lymphoma

open access: yesHematological Oncology, Volume 43, Issue 6, November 2025.
ABSTRACT Patients with Hodgkin lymphoma (HL) or peripheral T‐cell lymphoma (PTCL) who relapse after high‐dose chemotherapy (HDCT) have a dismal prognosis. Brentuximab‐vedotin (BV) is a CD30‐targeting antibody‐drug‐conjugate (ADC) used in first‐line‐, salvage‐, and maintenance‐therapy of HL, as well as first‐line‐ and salvage‐therapy of PTCL. In phase I
Christian Rausch   +7 more
wiley   +1 more source

Risk factors analysis of hypokalemia after radical resection of esophageal cancer and establishment of a nomogram risk prediction model

open access: yesFrontiers in Surgery
ObjectiveThis study aimed to explore the risk factors of hypokalemia after radical resection of esophageal cancer (EC) and establish a nomogram risk prediction model to evaluate hypokalemia risk after esophagectomy.
Guanqiang Yan   +7 more
doaj   +1 more source

Dextromethorphan Versus Dextrorphan: A Quantitative Comparison of Antitussive Potency Following Separate Administration of Metabolite

open access: yesThe Journal of Clinical Pharmacology, Volume 65, Issue 11, Page 1616-1625, November 2025.
Abstract To assess the antitussive effects of dextrorphan (DOR) relative to its parent compound, dextromethorphan (DEX) a double‐blind, randomized, placebo‐controlled crossover study was conducted in 23 healthy volunteers using citric acid cough challenge test after administering placebo, DEX, or DOR.
Saeed Rezaee   +3 more
wiley   +1 more source

Profound hypokalemia associated with severe diabetic ketoacidosis

open access: yesPediatric Diabetes, 2016
Hypokalemia is common during the treatment of diabetic ketoacidosis (DKA); however, severe hypokalemia at presentation prior to insulin treatment is exceedingly uncommon.
S. Davis   +5 more
semanticscholar   +1 more source

Nitrogen Scavengers: History, Clinical Considerations and Future Prospects

open access: yesJournal of Inherited Metabolic Disease, Volume 48, Issue 6, November 2025.
ABSTRACT Nitrogen scavengers play a critical role in treating acute and chronic hyperammonemia, especially in urea cycle disorders (UCDs), where impaired ammonia detoxification leads to toxic nitrogen accumulation. These agents complement low‐protein diets and urea cycle intermediates.
Sven Klassa, Johannes Häberle
wiley   +1 more source

Real-World Evidence on Levetiracetam-Induced Hypokalemia: An Active Comparator Cohort Study

open access: yesDrugs - Real World Outcomes
Background Levetiracetam is an anti-seizure medication (ASM) with an established safety profile. However, a potential safety signal of hypokalemia following levetiracetam use was published in the World Health Organization newsletter.
Ohoud Almadani   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy